- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-1-mer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 1 x K: POTASSIUM ION(Non-covalent)
- 6 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
P5S.4: 13 residues within 4Å:- Chain A: K.67, W.68, P.69, H.70, L.72, T.76, R.176
- Chain D: F.60, L.147, V.151, I.154, M.158, I.162
9 PLIP interactions:3 interactions with chain D, 6 interactions with chain A- Hydrophobic interactions: D:L.147, D:V.151, D:I.162, A:L.72, A:T.76
- Hydrogen bonds: A:W.68, A:R.176
- Salt bridges: A:H.175, A:R.176
P5S.8: 17 residues within 4Å:- Chain A: Q.57, F.60, I.154, V.155, I.162
- Chain B: V.64, K.67, W.68, P.69, H.70, L.72, T.76, K.170, Q.173, H.175, R.176
- Ligands: P5S.16
12 PLIP interactions:9 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:K.67, B:P.69, B:L.72, A:F.60, A:I.154, A:V.155
- Hydrogen bonds: B:W.68, B:Q.173
- Salt bridges: B:K.67, B:K.170, B:R.176, B:R.176
P5S.10: 9 residues within 4Å:- Chain B: Q.57, F.60, I.154, V.155, I.162
- Chain C: W.68, P.69, H.70, L.73
6 PLIP interactions:3 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:W.68, C:L.73, B:F.60, B:I.154
- Hydrogen bonds: C:W.68, B:Q.57
P5S.13: 10 residues within 4Å:- Chain C: F.60, V.151, I.154, I.162
- Chain D: L.66, K.67, W.68, P.69, T.76, R.176
11 PLIP interactions:4 interactions with chain C, 7 interactions with chain D- Hydrophobic interactions: C:F.60, C:V.151, C:I.154, C:I.162, D:P.69, D:P.69, D:T.76
- Hydrogen bonds: D:W.68, D:W.68
- Salt bridges: D:R.176, D:R.176
P5S.16: 11 residues within 4Å:- Chain A: V.59, L.85
- Chain B: R.176
- Chain E: F.41, I.42, P.45, I.46, F.132, K.134, L.135
- Ligands: P5S.8
9 PLIP interactions:2 interactions with chain B, 2 interactions with chain A, 5 interactions with chain E- Hydrogen bonds: B:R.176
- Salt bridges: B:R.176, E:K.134, E:K.134
- Hydrophobic interactions: A:V.59, A:L.85, E:I.42, E:P.45, E:I.46
P5S.24: 16 residues within 4Å:- Chain E: N.72, I.76, F.79, I.80, F.83, V.84, L.224, K.227, G.228, L.301, F.305, L.364, T.371, F.372, A.375
- Ligands: PTY.19
14 PLIP interactions:14 interactions with chain E- Hydrophobic interactions: E:I.76, E:F.79, E:F.83, E:V.84, E:L.224, E:K.227, E:F.305, E:F.305, E:L.364, E:F.372, E:F.372, E:A.375
- Salt bridges: E:K.227, E:R.298
- 5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.5: 13 residues within 4Å:- Chain A: L.84, M.88, W.91, L.100, H.115, S.116, F.117
- Chain E: L.3, A.4, F.5, Y.15, L.104, M.112
7 PLIP interactions:3 interactions with chain A, 4 interactions with chain E- Hydrophobic interactions: A:L.84, A:F.117, E:L.3
- Hydrogen bonds: A:F.117, E:F.5, E:Y.15, E:Y.15
POV.7: 9 residues within 4Å:- Chain A: P.143, I.146
- Chain B: L.84, M.88, W.91, L.100, H.115, S.116, F.117
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:P.143, A:I.146, B:L.84
- Hydrogen bonds: B:F.117
POV.11: 7 residues within 4Å:- Chain C: L.84, M.88, W.91, H.115, S.116, F.117, S.118
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:L.84, C:L.84, C:F.117
- Hydrogen bonds: C:W.91, C:S.116, C:F.117
POV.14: 8 residues within 4Å:- Chain C: P.143
- Chain D: M.88, W.91, L.100, H.115, S.116, F.117, S.118
4 PLIP interactions:1 interactions with chain C, 3 interactions with chain D- Hydrophobic interactions: C:P.143, D:F.117, D:F.117
- Hydrogen bonds: D:F.117
POV.20: 8 residues within 4Å:- Chain E: H.67, F.68, G.70, H.71, N.72, L.73, N.188, P.220
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:L.73
- Hydrogen bonds: E:G.70, E:H.71, E:N.72
- 5 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
PTY.15: 6 residues within 4Å:- Chain A: V.89, L.92, L.144
- Chain E: V.21, L.22, I.148
3 PLIP interactions:1 interactions with chain E, 2 interactions with chain A- Hydrophobic interactions: E:I.148, A:V.89, A:L.144
PTY.19: 14 residues within 4Å:- Chain E: L.47, F.48, W.51, Q.54, W.75, F.79, L.82, V.121, V.122, H.125, N.126, T.129
- Ligands: PTY.21, P5S.24
10 PLIP interactions:10 interactions with chain E- Hydrophobic interactions: E:L.47, E:F.48, E:W.75, E:F.79, E:L.82, E:V.121
- Hydrogen bonds: E:Q.54, E:T.129
- Salt bridges: E:H.125, E:H.125
PTY.21: 8 residues within 4Å:- Chain E: W.65, H.125, V.222, N.223, L.225, S.226, W.231
- Ligands: PTY.19
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:W.231, E:W.231
- Hydrogen bonds: E:N.223, E:S.226
- Salt bridges: E:H.125
PTY.22: 6 residues within 4Å:- Chain E: I.89, A.90, I.93, F.114, N.354, Y.356
5 PLIP interactions:5 interactions with chain E- Hydrophobic interactions: E:I.89, E:A.90, E:F.114
- Hydrogen bonds: E:N.354, E:Y.356
PTY.23: 9 residues within 4Å:- Chain E: L.311, A.315, L.318, C.319, F.321, L.352, L.361, A.365, L.451
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:A.315, E:L.361, E:L.451
- 1 x BJX: Repaglinide(Non-covalent)
BJX.17: 14 residues within 4Å:- Chain A: M.1, S.3
- Chain E: Y.377, W.430, L.434, N.437, T.588, L.592, S.595, V.596, N.1245, R.1246, W.1297, R.1300
13 PLIP interactions:1 interactions with chain A, 12 interactions with chain E- Hydrophobic interactions: A:S.3, E:Y.377, E:L.434, E:L.434, E:T.588, E:L.592, E:L.592, E:V.596, E:W.1297, E:W.1297
- Hydrogen bonds: E:N.437
- Salt bridges: E:R.1246, E:R.1300
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sung, M.W. et al., Ligand-mediated Structural Dynamics of a Mammalian Pancreatic K ATP Channel. J.Mol.Biol. (2022)
- Release Date
- 2022-08-31
- Peptides
- ATP-sensitive inward rectifier potassium channel 11: ABCD
ATP-binding cassette sub-family C member 8: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-1-mer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 1 x K: POTASSIUM ION(Non-covalent)
- 6 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
- 5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 5 x PTY: PHOSPHATIDYLETHANOLAMINE(Non-covalent)
- 1 x BJX: Repaglinide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sung, M.W. et al., Ligand-mediated Structural Dynamics of a Mammalian Pancreatic K ATP Channel. J.Mol.Biol. (2022)
- Release Date
- 2022-08-31
- Peptides
- ATP-sensitive inward rectifier potassium channel 11: ABCD
ATP-binding cassette sub-family C member 8: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.